skip to main content

Denosumab delayed dose — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModerateMusculoskeletal TherapeuticsDenosumab delayed doseGPhC CRA

A patient receiving denosumab injections for osteoporosis says her next dose is two months overdue because she missed an appointment. She asks whether delay matters. What monitoring is required?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: D — Refer promptly to the prescriber or clinic to arrange review and dosing plan

Denosumab should be administered on schedule because delay or stopping can increase fracture risk. The patient needs prompt contact with the responsible clinic or prescriber. Calcium and vitamin D may be part of care but do not replace denosumab planning.

Reference: BNF; NICE CKS